Paper18316005
Small cell lung cancer.
Sher T and 2 others. Mayo Clin Proc, 2008. Cited by 412 papers, by iCite.
Cite this record
ConductScience Library. Small cell lung cancer. Papers, record 18316005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18316005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Small Cell | Major topic |
| Lung Neoplasms | Major topic |
| Combined Modality Therapy | |
| Diagnosis, Differential | |
| Humans | |
| Morbidity | |
| Prognosis | |
| Survival Rate | |
| United States |
Source PubMed
Cited by270
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 412 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964983 | Overcoming EGFR Resistance by Monovalent and Bident Inhibitors Targeting Cys775. | ACS Cent Sci | 2026 | https://conductscience.org/library/papers/42964983 | PubMed |
| 42464189 | Efficacy and safety of metronomic oral vinorelbine in elderly patients with locally advanced and metastatic non-small cell lung cancer. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42464189 | PubMed |
| 42444944 | C1ORF112 drives lung adenocarcinoma progression through e2f8-mediated transcriptional activation. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42444944 | PubMed |
| 42396928 | The Oncogenic and Tumor-Suppressive Roles of SNHG18: A Double-Edged Long Noncoding RNA in Cancer. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42396928 | PubMed |
| 42218725 | Residential radon exposure and lung cancer histology and stage: a population-based ecological study in Central Germany. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/42218725 | PubMed |
| 42198435 | Integrative In Silico Identification of TP53-Associated Drug Repurposing Candidates in Lung Adenocarcinoma. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198435 | PubMed |
| 42157924 | Activation of GABBR1 by New Ligand Valerate Transcriptionally Regulates ATF4-NRF2-CXCL13 Axis Mediating CD8+ T Cell Anti-Tumor Immunity. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42157924 | PubMed |
| 42109065 | Impact of EGFR Mutations on Survival and Clinical Response in Non-Small Cell Lung Cancer in a Tertiary Care Hospital. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42109065 | PubMed |
| 42039433 | CXCL-CXCR2 signaling drives cancer-endothelium interactions in SCLC metastatic seeding. | bioRxiv | 2026 | https://conductscience.org/library/papers/42039433 | PubMed |
| 41933080 | Label-free pathological subtyping of non-small cell lung cancer using deep classification and virtual immunohistochemical staining. | NPJ Digit Med | 2026 | https://conductscience.org/library/papers/41933080 | PubMed |
| 41901620 | The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41901620 | PubMed |
| 41821616 | Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41821616 | PubMed |
| 41669368 | From Gefitinib to Amivantamab: Progress and Perspectives of Therapies Targeting the Epidermal Growth Factor Receptor in the Era of Precision Oncology. | J Cancer Prev | 2026 | https://conductscience.org/library/papers/41669368 | PubMed |
| 41649756 | The mechanistic role of Wilms tumor 1-associated protein in cancer pathogenesis, immunity, immunotherapy, and therapy resistance. | Invest New Drugs | 2026 | https://conductscience.org/library/papers/41649756 | PubMed |
| 41613628 | Rarity of Acute Pancreatitis as an Initial Presentation of Lung Carcinoma. | Case Rep Surg | 2026 | https://conductscience.org/library/papers/41613628 | PubMed |
| 41378295 | The CD300c antibody CL7 suppresses tumor growth by regulating the tumor microenvironment in non-small cell lung carcinoma. | Front Oncol | 2025 | https://conductscience.org/library/papers/41378295 | PubMed |
| 41333366 | Clinical outcomes of patients with advanced EGFR mutated nonsquamous cell lung carcinoma treated at a tertiary care hospital. | Ecancermedicalscience | 2025 | https://conductscience.org/library/papers/41333366 | PubMed |
| 41174769 | Real-world efficacy of postoperative adjuvant EGFR-TKI therapy for stage IA2-IA3 lung adenocarcinoma with high-risk pathological factors. | World J Surg Oncol | 2025 | https://conductscience.org/library/papers/41174769 | PubMed |
| 41049163 | Automated detection and characterization of small cell lung cancer liver metastasis on computed tomography. | Diagn Interv Radiol | 2026 | https://conductscience.org/library/papers/41049163 | PubMed |
| 41023740 | Unraveling the molecular-pathological characteristics and cellular complexity of the tumor immune microenvironment in metastatic non-small cell lung cancer. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/41023740 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18316005
GET https://conductscience.org/api/papers/v1/18316005/cited_by?page=2